De Zeng

938 total citations
44 papers, 617 citations indexed

About

De Zeng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, De Zeng has authored 44 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 19 papers in Oncology and 10 papers in Cancer Research. Recurrent topics in De Zeng's work include Epigenetics and DNA Methylation (9 papers), Cancer Cells and Metastasis (8 papers) and Ferroptosis and cancer prognosis (5 papers). De Zeng is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Cancer Cells and Metastasis (8 papers) and Ferroptosis and cancer prognosis (5 papers). De Zeng collaborates with scholars based in China, Netherlands and Macao. De Zeng's co-authors include Haoyu Lin, Yuanke Liang, Chunfa Chen, Yingsheng Xiao, Xiaolong Wei, Guo‐Jun Zhang, Xiaofeng Lu, Shuming Sun, Yang Wu and Qin Xie and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Molecules.

In The Last Decade

De Zeng

37 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
De Zeng China 15 392 194 194 127 58 44 617
André Schultz United States 6 358 0.9× 211 1.1× 205 1.1× 92 0.7× 65 1.1× 12 601
Guoyin Li China 13 343 0.9× 156 0.8× 230 1.2× 111 0.9× 56 1.0× 35 584
Kristen Rodgers United States 5 586 1.5× 150 0.8× 206 1.1× 142 1.1× 59 1.0× 14 751
Yang Peng China 13 228 0.6× 206 1.1× 204 1.1× 123 1.0× 42 0.7× 44 485
Jianguo Lai China 13 303 0.8× 159 0.8× 248 1.3× 126 1.0× 31 0.5× 42 511
Xiaojian Ni China 13 263 0.7× 201 1.0× 185 1.0× 60 0.5× 54 0.9× 34 475
Shuiping Gao China 13 263 0.7× 229 1.2× 194 1.0× 99 0.8× 38 0.7× 28 539
Matias Casás‐Selves United States 8 350 0.9× 175 0.9× 126 0.6× 71 0.6× 75 1.3× 9 549
Erwin Tomasich Austria 13 336 0.9× 179 0.9× 187 1.0× 120 0.9× 72 1.2× 31 547
Zehua Wang China 13 275 0.7× 185 1.0× 187 1.0× 103 0.8× 126 2.2× 32 562

Countries citing papers authored by De Zeng

Since Specialization
Citations

This map shows the geographic impact of De Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by De Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites De Zeng more than expected).

Fields of papers citing papers by De Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by De Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by De Zeng. The network helps show where De Zeng may publish in the future.

Co-authorship network of co-authors of De Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of De Zeng. A scholar is included among the top collaborators of De Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with De Zeng. De Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Lin, Jiajia, et al.. (2025). Esophageal cancer trends in the US from 1992 to 2019 with projections to 2044 using SEER data. Scientific Reports. 15(1). 22423–22423.
5.
Wang, Shimeng, Guan‐Yuan Chen, Chengyu Wu, et al.. (2024). RNA-binding proteins in breast cancer: Biological implications and therapeutic opportunities. Critical Reviews in Oncology/Hematology. 195. 104271–104271. 4 indexed citations
6.
7.
Li, Meifang, Shaozhong Li, De Zeng, et al.. (2023). Notch1 promotes resistance to cisplatin by up-regulating Ecto-5′-nucleotidase (CD73) in triple-negative breast cancer cells. Cell Death Discovery. 9(1). 204–204. 11 indexed citations
8.
Chen, Wen-Jia, Jiaxin Shen, Maria R. De Miglio, De Zeng, & Leonardo A. Sechi. (2023). Endogenous retrovirus group FRD member 1 is a potential biomarker for prognosis and immunotherapy for kidney renal clear cell carcinoma. Frontiers in Cellular and Infection Microbiology. 13. 1252905–1252905. 4 indexed citations
9.
Liang, Yuanke, Jinxing Liu, Kaiyuan Huang, et al.. (2023). HER2-targeting two-dimensional black phosphorus as a nanoplatform for chemo-photothermal therapy in breast cancer. Materials Today Bio. 23. 100812–100812. 6 indexed citations
10.
Lau, Joseph T. F., et al.. (2023). Prevalence and factors of COVID-19 vaccine refusal among solid cancer patients in China: an application of the health belief model. Frontiers in Public Health. 11. 1236376–1236376. 1 indexed citations
11.
Liang, Yuanke, Xiaoling Zhou, Qin Xie, et al.. (2022). CD146 interaction with integrin β1 activates LATS1-YAP signaling and induces radiation-resistance in breast cancer cells. Cancer Letters. 546. 215856–215856. 23 indexed citations
12.
Zhang, Yong‐Qu, Yuanke Liang, Yang Wu, et al.. (2021). Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN. Cell Death and Disease. 12(6). 502–502. 34 indexed citations
13.
Liang, Yuanke, Si-Qi Qiu, Yingsheng Xiao, et al.. (2021). CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer. Frontiers in Oncology. 11. 710286–710286. 40 indexed citations
14.
Xie, Qin, Yingsheng Xiao, Yi‐Chun Chen, et al.. (2020). FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer. Cancer Cell International. 20(1). 562–562. 16 indexed citations
15.
Zeng, De, Haoyu Lin, Yuling Zhang, et al.. (2020). A negative binomial regression model for risk estimation of 0–2 axillary lymph node metastases in breast cancer patients. Scientific Reports. 10(1). 21856–21856. 3 indexed citations
16.
Zeng, De, Chunfa Chen, Shuming Sun, et al.. (2019). <p><em>Long noncoding RNA H19</em> is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma</p>. Cancer Management and Research. Volume 11. 2059–2072. 26 indexed citations
17.
Wei, Xiaolong, De Zeng, Jundong Wu, et al.. (2019). Over-expression of both VEGF-C and Twist predicts poor prognosis in human breast cancer. Clinical & Translational Oncology. 21(9). 1250–1259. 16 indexed citations
18.
Chen, Chunfa, Yuling Zhang, Shuming Sun, et al.. (2019). Predictive Value of Preoperative Multidetector-Row Computed Tomography for Axillary Lymph Nodes Metastasis in Patients With Breast Cancer. Frontiers in Oncology. 8. 666–666. 23 indexed citations
19.
Li, Meifang, Min Chen, Zun Wang, et al.. (2019). GATA Binding Protein 3 Boosts Extracellular ATP Hydrolysis and Inhibits Metastasis of Breast Cancer by Up-regulating Ectonucleoside Triphosphate Diphosphohydrolase 3. International Journal of Biological Sciences. 15(12). 2522–2537. 8 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André Schultz Breakdown of academic impact, for papers by Guoyin Li Breakdown of academic impact, for papers by Kristen Rodgers Breakdown of academic impact, for papers by Yang Peng Breakdown of academic impact, for papers by Jianguo Lai Breakdown of academic impact, for papers by Xiaojian Ni Breakdown of academic impact, for papers by Shuiping Gao Breakdown of academic impact, for papers by Matias Casás‐Selves Breakdown of academic impact, for papers by Erwin Tomasich Breakdown of academic impact, for papers by Zehua Wang
Rankless by CCL
2026